Endra Life Sciences has partnered with GE Healthcare to speed up the development of its clinical ultrasound capabilities.
The global collaboration agreement includes the development of Endra’s Thermo Acoustic Enhanced UltraSound (TAEUS) technology to allow existing ultrasound systems to visualize tissue function, composition and monitor different therapeutic interventions at the point of care.
Endra said the new technology can be used in a range of clinical applications, including non-invasively quantifying fat in the liver for diagnosis of fatty liver disease.
As part of the deal, GE Healthcare will help Endra to commercialize TAEUS technology for use in a fatty liver application.
GE Healthcare will also provide equipment and technical advice to Endra, in addition to facilitating introductions to its clinical ultrasound customers.
Ender will provide GE Healthcare with certain manufacturing rights for the technology and licensing rights for the target application.
Endra CEO Francois Michelon said: "We are thrilled to partner with GE, the ultrasound market leader, to help us accelerate the development and commercialization of Endra’s TAEUS technology."
GE Healthcare radiology and vascular ultrasound general manager and vice president Brian McEathron said: We believe that Endra’s technology has the potential to bring significant new capabilities to ultrasound – which aligns well with GE Healthcare’s mission of broadening access to high-quality, cost-effective healthcare."